Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 5.65 Million USD | 6.57% |
| 2019 | 5.3 Million USD | 24.27% |
| 2018 | 4.26 Million USD | -18.14% |
| 2017 | 5.21 Million USD | -17.3% |
| 2016 | 6.3 Million USD | 83.51% |
| 2015 | 3.43 Million USD | 0.0% |
| 2012 | 4.14 Million USD | -10.11% |
| 2011 | 4.6 Million USD | -9.07% |
| 2010 | 5.06 Million USD | 17.17% |
| 2009 | 4.32 Million USD | 50.64% |
| 2008 | 2.87 Million USD | 252.95% |
| 2007 | 813.32 Thousand USD | 118.02% |
| 2006 | 373.05 Thousand USD | -72.1% |
| 2005 | 1.33 Million USD | 46.21% |
| 2004 | 914.44 Thousand USD | 22.0% |
| 2003 | 749.56 Thousand USD | -51.5% |
| 2002 | 1.54 Million USD | 2.25% |
| 2001 | 1.51 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 5.46 Million USD | -3.25% |
| 2021 Q2 | 5.33 Million USD | -2.52% |
| 2021 Q3 | 5.34 Million USD | 0.2% |
| 2020 Q4 | 5.65 Million USD | -6.45% |
| 2020 FY | 5.65 Million USD | 6.57% |
| 2020 Q2 | 5.8 Million USD | -7.44% |
| 2020 Q3 | 6.04 Million USD | 4.13% |
| 2020 Q1 | 6.27 Million USD | 18.2% |
| 2019 FY | 5.3 Million USD | 24.27% |
| 2019 Q2 | 5.12 Million USD | 31.24% |
| 2019 Q3 | 5.12 Million USD | 0.0% |
| 2019 Q4 | 5.3 Million USD | 3.55% |
| 2019 Q1 | 3.9 Million USD | -6.76% |
| 2018 Q4 | 4.18 Million USD | -5.67% |
| 2018 FY | 4.26 Million USD | -18.14% |
| 2018 Q1 | 4.61 Million USD | -10.0% |
| 2018 Q2 | 4.59 Million USD | -0.62% |
| 2018 Q3 | 4.43 Million USD | -3.33% |
| 2017 Q3 | 5.31 Million USD | 0.0% |
| 2017 Q1 | 5.91 Million USD | -4.91% |
| 2017 FY | 5.21 Million USD | -17.3% |
| 2017 Q4 | 5.13 Million USD | -3.46% |
| 2016 Q1 | 4.5 Million USD | 34.2% |
| 2016 FY | 6.3 Million USD | 83.51% |
| 2016 Q4 | 6.22 Million USD | 5.16% |
| 2016 Q3 | 5.91 Million USD | -8.0% |
| 2016 Q2 | 6.43 Million USD | 42.68% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q4 | 3.35 Million USD | 0.0% |
| 2015 Q1 | 3.78 Million USD | 0.0% |
| 2015 Q2 | 3.61 Million USD | -4.52% |
| 2015 FY | 3.43 Million USD | 0.0% |
| 2013 Q1 | 4.19 Million USD | 1.36% |
| 2013 Q3 | 4.79 Million USD | 30.28% |
| 2013 Q2 | 3.67 Million USD | -12.41% |
| 2012 Q1 | 4.7 Million USD | 2.18% |
| 2012 Q2 | 4.65 Million USD | -1.11% |
| 2012 Q3 | 4.47 Million USD | -3.92% |
| 2012 Q4 | 4.14 Million USD | -7.42% |
| 2012 FY | 4.14 Million USD | -10.11% |
| 2011 Q4 | 4.6 Million USD | -10.98% |
| 2011 Q2 | 5.4 Million USD | 10.98% |
| 2011 FY | 4.6 Million USD | -9.07% |
| 2011 Q1 | 4.86 Million USD | -3.96% |
| 2011 Q3 | 5.17 Million USD | -4.16% |
| 2010 FY | 5.06 Million USD | 17.17% |
| 2010 Q1 | 4.39 Million USD | 1.57% |
| 2010 Q2 | 4.52 Million USD | 2.91% |
| 2010 Q3 | 4.45 Million USD | -1.53% |
| 2010 Q4 | 5.06 Million USD | 13.83% |
| 2009 Q4 | 4.32 Million USD | 24.85% |
| 2009 Q1 | 2.55 Million USD | -10.87% |
| 2009 FY | 4.32 Million USD | 50.64% |
| 2009 Q2 | 3.47 Million USD | 35.88% |
| 2009 Q3 | 3.46 Million USD | -0.37% |
| 2008 FY | 2.87 Million USD | 252.95% |
| 2008 Q1 | 1.08 Million USD | 33.07% |
| 2008 Q2 | 1.41 Million USD | 30.93% |
| 2008 Q3 | 1.67 Million USD | 18.34% |
| 2008 Q4 | 2.87 Million USD | 71.18% |
| 2007 FY | 813.32 Thousand USD | 118.02% |
| 2007 Q2 | 646.12 Thousand USD | 49.23% |
| 2007 Q1 | 432.98 Thousand USD | 16.06% |
| 2007 Q3 | 664.18 Thousand USD | 2.79% |
| 2007 Q4 | 813.32 Thousand USD | 22.45% |
| 2006 FY | 373.05 Thousand USD | -72.1% |
| 2006 Q4 | 373.05 Thousand USD | -80.19% |
| 2006 Q3 | 1.88 Million USD | 40.33% |
| 2006 Q1 | 1.73 Million USD | 30.09% |
| 2006 Q2 | 1.34 Million USD | -22.83% |
| 2005 Q1 | 3.03 Million USD | 231.65% |
| 2005 Q4 | 1.33 Million USD | -24.18% |
| 2005 Q3 | 1.76 Million USD | -24.19% |
| 2005 Q2 | 2.32 Million USD | -23.3% |
| 2005 FY | 1.33 Million USD | 46.21% |
| 2004 FY | 914.44 Thousand USD | 22.0% |
| 2004 Q4 | 914.44 Thousand USD | -6.91% |
| 2004 Q3 | 982.35 Thousand USD | -10.97% |
| 2004 Q2 | 1.1 Million USD | -20.31% |
| 2004 Q1 | 1.38 Million USD | 84.72% |
| 2003 Q2 | 1.33 Million USD | -19.27% |
| 2003 FY | 749.56 Thousand USD | -51.5% |
| 2003 Q4 | 749.56 Thousand USD | -42.56% |
| 2003 Q1 | 1.64 Million USD | 6.71% |
| 2003 Q3 | 1.3 Million USD | -1.99% |
| 2002 Q2 | 1.68 Million USD | 19.33% |
| 2002 Q1 | 1.41 Million USD | 0.0% |
| 2002 FY | 1.54 Million USD | 2.25% |
| 2002 Q3 | 1.73 Million USD | 3.08% |
| 2002 Q4 | 1.54 Million USD | -10.96% |
| 2001 FY | 1.51 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | NaN% |
| Allstar Health Brands, Inc. | 220.00 USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 567.74 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 1.04 Million USD | 100.0% |
| Health Advance Inc. | 501.27 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | 3.2 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 787.21 Million USD | 100.0% |
| MedGen, Inc. | 0.79 USD | 100.0% |
| Omni Health, Inc. | 5.53 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 451.08 Thousand USD | 100.0% |
| Pineapple, Inc. | 7.83 Million USD | 100.0% |
| ScripsAmerica, Inc. | 5.64 Million USD | 100.0% |